Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Investments:
Available-for-sale, Debt Securities, Excluding Securities Valued at Fair Value Option	$ 17,848	$ 18,713
Fixed maturities, at fair value using the fair value option	1,197	1,328
Equity Securities, FV-NI, Current	66	65
Short-term investments	20	86
Financing Receivable, after Allowance for Credit Loss, Current	3,613	4,026
Policy loans	163	161
Limited partnerships/corporations	1,227	1,046
Derivatives	239	213
Other Investments	94	88
Total investments	25,556	26,524
Cash and cash equivalents	516	186
Short-term investments under securities loan agreements, including collateral delivered	839	789
Accrued investment income	276	283
Premiums and Other Receivables, Net	2,560	2,899
Deferred policy acquisition costs and Value of business acquired	907	920
Deferred Income Tax Assets, Net	662	633
Other assets (net of allowance for credit loss of $0 as of 2024 and 2023)	1,396	1,726
Separate Account Asset	98,579	90,282
Total assets	131,291	124,242
Liabilities and Shareholder's Equity
Future policy benefits and contract owner account balances	29,268	30,577
Payables under securities loan and repurchase agreements, including collateral held	897	692
Related Party Deposit Liabilities	100	173
Derivatives	268	299
Other liabilities	639	679
Liabilities related to separate accounts	98,579	90,282
Total liabilities	129,751	122,702
Commitments and Contingencies (Note 15)
Shareholder's equity:
Common Stock, Value, Issued	3	3
Additional paid-in capital	2,754	2,770
Accumulated other comprehensive income (loss)	(1,644)	(1,531)
Retained earnings	427	298
Total shareholder's equity	1,540	1,540
Total liabilities and shareholder's equity	131,291	124,242
Collateral Pledged
Investments:
Debt Securities, Available-for-Sale, Restricted	$ 1,089	$ 798